An Investigational Immuno-Therapy Study of Experimental Medication BMS-986242 Given in Combination With Nivolumab in Patients With Advanced Cancer
Clinical trial NCT03351231 · TERMINATED
Trial details
- NCT number
- NCT03351231
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2018-08-28
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.